SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001999371-24-002376
Filing Date
2024-02-14
Accepted
2024-02-14 20:39:50
Documents
2
Group Members
DEVESH GANDHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP mtem-sc13g_123123.htm SC 13G 90544
2 JOINT FILING AGREEMENT ex-a.htm EX-99.(A) 6613
  Complete submission text file 0001999371-24-002376.txt   98879
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Subject) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81377 | Film No.: 24641673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 20 PARK PLAZA 4TH FLOOR BOSTON MA 02116 617.284.6952
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001816307 (see all company filings)

IRS No.: 834542901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G